Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 74 Colorectal Neoplasms 41 Central Nervous System Neoplasms 37 Colonic Neoplasms 36 Rectal Neoplasms 34 Glioblastoma 23 Carcinoma, Non-Small-Cell Lung 21 Gliosarcoma 20 Stomach Neoplasms 18 Lung Neoplasms 18 Pancreatic Neoplasms 16 Head and Neck Neoplasms 16 Sarcoma 14 Ovarian Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 13 Prostatic Neoplasms 12 Neoplasm Metastasis 11 Melanoma 11 Esophageal Neoplasms 11 Carcinoma, Ovarian Epithelial 11 Carcinoma, Intraductal, Noninfiltrating 11 Astrocytoma 11 Fallopian Tube Neoplasms 10 Brain Neoplasms 10 Uterine Cervical Neoplasms 9 Kidney Neoplasms 9 Breast Carcinoma In Situ 9 Liver Neoplasms 8 Breast Neoplasms, Male 8 Adenocarcinoma Of Esophagus 8

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Chemotherapy, Adjuvant × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡